-
1
المؤلفون: Darren Abbanat, Enos Bernasconi, Stéphan Juergen Harbarth, Ingrid van den Nieuwenhof, Anette Kuhn, P. Martín, Serge de Vallière, Stefan Thoelen, Rahel Frölich, Germie van den Dobbelsteen, Todd A. Davies, Christoph Hatz, Tanja Hülder, Angela Huttner, Anita M. Dreyer, Volker Viereck, Veronica Gambillara Fonck, Gloria Ryu, Kerstin Kling, Sabine Gröger, Jan Poolman, Cristina Alaimo, Alena Hornacek, David Scheiner, Kellen Fae, Tilemachos Kavvadias
المصدر: The Lancet Infectious Diseases, Vol. 17, No 5 (2017) pp. 528-537
مصطلحات موضوعية: Adult, 0301 basic medicine, Serotype, medicine.medical_specialty, Extraintestinal Pathogenic Escherichia coli, Urinary Tract Infections/prevention & control, Placebo, Escherichia coli Vaccines/administration & dosage/therapeutic use, law.invention, 03 medical and health sciences, Immunogenicity, Vaccine, Randomized controlled trial, law, Internal medicine, medicine, Humans, Single-Blind Method, Vaccination/methods, 610 Medicine & health, Adverse effect, Aged, ddc:616, Escherichia coli Vaccines, business.industry, Immunogenicity, Incidence (epidemiology), Vaccination, Middle Aged, Extraintestinal Pathogenic Escherichia coli/isolation & purification, Treatment Outcome, 030104 developmental biology, Infectious Diseases, Urinary Tract Infections, Immunology, Female, business